Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 704

1.

Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.

Nadiminty N, Lou W, Lee SO, Mehraein-Ghomi F, Kirk JS, Conroy JM, Zhang H, Gao AC.

Clin Cancer Res. 2006 Mar 1;12(5):1420-30. Erratum in: Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3552.

2.

Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.

Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM.

Clin Cancer Res. 2003 Jul;9(7):2587-97.

3.

Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.

Yonou H, Horiguchi Y, Ohno Y, Namiki K, Yoshioka K, Ohori M, Hatano T, Tachibana M.

Prostate. 2007 Jun 1;67(8):840-8.

PMID:
17394194
4.

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation.

Chen G, Sircar K, Aprikian A, Potti A, Goltzman D, Rabbani SA.

Cancer. 2006 Jul 15;107(2):289-98.

5.

Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.

Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM.

Cancer Res. 2001 Jul 15;61(14):5652-9.

6.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.

Postiglione L, Domenico GD, Montagnani S, Spigna GD, Salzano S, Castaldo C, Ramaglia L, Sbordone L, Rossi G.

Calcif Tissue Int. 2003 Jan;72(1):85-97. Epub 2002 Sep 18.

PMID:
12232677
7.
8.
9.

Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts.

Jacobson A, Johansson S, Branting M, Melhus H.

Biochem Biophys Res Commun. 2004 Sep 10;322(1):162-7.

PMID:
15313187
10.

Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin.

Evans BA, Elford C, Pexa A, Francis K, Hughes AC, Deussen A, Ham J.

J Bone Miner Res. 2006 Feb;21(2):228-36. Epub 2005 Oct 31.

11.

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.

Lin DL, Tarnowski CP, Zhang J, Dai J, Rohn E, Patel AH, Morris MD, Keller ET.

Prostate. 2001 May 15;47(3):212-21.

PMID:
11351351
12.

Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.

Rifas L, Arackal S, Weitzmann MN.

J Cell Biochem. 2003 Mar 1;88(4):650-9.

PMID:
12577299
13.

Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells.

Zahanich I, Graf EM, Heubach JF, Hempel U, Boxberger S, Ravens U.

J Bone Miner Res. 2005 Sep;20(9):1637-46. Epub 2005 May 31.

14.

CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway.

Villa I, Mrak E, Rubinacci A, Ravasi F, Guidobono F.

Am J Physiol Cell Physiol. 2006 Sep;291(3):C529-37. Epub 2006 Apr 12.

15.

Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.

Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET.

Cancer Res. 2003 Nov 15;63(22):7883-90.

16.

Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells.

Maddi A, Hai H, Ong ST, Sharp L, Harris M, Meghji S.

Bone. 2006 Aug;39(2):283-8. Epub 2006 Mar 29.

PMID:
16567138
17.

Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.

Jung K, Lein M, Ringsdorf M, Roigas J, Schnorr D, Loening SA, Staack A.

J Urol. 2006 Oct;176(4 Pt 1):1326-31.

PMID:
16952623
18.

Effect of human granulocyte macrophage-colony stimulating factor on differentiation and apoptosis of the human osteosarcoma cell line SaOS-2.

Postiglione L, Di Domenico G, Giordano-Lanza G, Ladogana P, Turano M, Castaldo C, Di Meglio F, Cocozza S, Montagnani S.

Eur J Histochem. 2003;47(4):309-16.

PMID:
14706926
19.

Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells.

Mori K, Berreur M, Blanchard F, Chevalier C, Guisle-Marsollier I, Masson M, RĂ©dini F, Heymann D.

Oncol Rep. 2007 Dec;18(6):1365-71.

PMID:
17982618
20.
Items per page

Supplemental Content

Write to the Help Desk